Daftar Pustaka

1. Nikpour M, Stevens WM, Herrick AL, Proudman SM. Epidemiology of

Systemic Sclerosis in: Best Practice & Research Clinical Rheumatology. 2010:
857-869.
2. Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Stadler M, Diot P, Lemarie
E, Laspargues G. Sistemic Sclerosis and Occupational Risk Factors: a Case-
control Study, Occup Environ Med, 2002; 59: 545-549.
3. Haustein UF. Systemic SclerosisAn Update in: Department of Dermatology,
Venereology, and Allergology, Leipzig university and Saxon Academy of
sciences, Leipzig, Germany, CE Update, 2011; Vol: 42: 562-572.
4. Pattanaik D, Brown M, Postlethwaite AE. Vascular Involvement in Systemic
Sclerosis (Scleroderma) in: Journal of Inflammation Research, 2011, 105-125.
5. Plastiras SC, Toumanidis ST. Systemic Sclerosis: The He art of the Matter,
Hellenic J cardiol, 2012; 53: 287-300.
6. Barnes J, Mayes MD.Epidemiology of Systemic Sclerosis in: Incidence,
Prevalence, Survival, Risk Factors, M, and alignancy, and Environmental
Triggers, Current opinion, 2012, 1040-8711.
7. Penn H, Howie AJ, Kingdon EJ et al. Scleroderma renal crisis: patient
characteristics and long-term outcomes. Q J Med 2007;100:48594.
8. S. Sierakowski, Sieskiewiez GE, Bielecka KO. The Importance of
Early Diagnosis of Systemic Sclerosis in: Department of Rheumatology and
Internal Disease, Medical University of Bialystok, Poland, Vol. 5, 2005, 232-233.
9. Chapman P. Systemic Sclerosis in: Scleroderma, Clinical Practice, 2006, Vol. .4,
17-18.
10. Eisenberg ME, Nguyen BY, Karnath BM. Clinical Features of Systemic Sclerosis
in: Review of Clinical Signs, University Boulevard, Galveston, 2008, 32-38.
11. Merkel PA, Scleroderma (Also Known as Systemic Sclerosis) in: American
College of Rheumatology, 2013, 1-5.
12. Fitzpatricks. Scleroderma in:ColorAtlas and Synopsis of Clinical
Dermatology, 15thed. New York: The McGraw-Hill Companies Inc, 2005, 398-
403
13. Gilliland BC. Systemic Sclerosis (Scleroderma) and Related Disorder in: Fauci
AS (eds). Harrisons Principles of Internal Medicine 16th edition. New York, Mc
Graw-Hill, 2005; 1979-1990.
14. Varga J. Systemic Sclerosis (Scleroderma) and Related Disorders in:
Eugene B, Anthoni et all, eds. Harrisons Principles of Internal Medicine,17th
ed. New York: The McGraw-Hill Companies Inc, 2008, 316, 2096-2106.
15. Setiyohadi B. Sklerosis Sistemik in: Sudoyo AW, Setiyohadi B, eds. Buku Ajar
Ilmu Penyakit Dalam. Edisi V. Jakarta: Balai penerbit FKUI, 2010: 1239-44.
16. M aureen D. Systemic sklerosis in: John H, Klippel, Leslie J, Patience H, eds.
Primer On The Rheumatic Diseases, 13thed. New York: Springer Science +
Business Media, 2008, 17, 343-62
17. James R. Scleroderma in: Edward D, et all, eds. Kelleys Textbook of
Rheumatology, Vol II. USA: Elseiver Saunders, 2005, 79, 1279-1308.
18. Van De Hoogen Frank et.al. Arthritis & Rheumatism in: 2013 Classification
Criteria for Systemic Sclerosis, An American College of
Rheumatology/European League Against Rheumatism Collaborative Initiative,
2013, Vol: 65; 2737-2747.
19. Gabrielli A MD, Avvedimento EV MD, Krieg T MD. Mechanism of Disease
Scleroderma in: The New england Journal of Medicine. Massachusetts Medical
Society; 2009, 1989-2003.
20. National Heart, Lung, and Blood Institute (NHLBI). Scleroderma
Lung Study. US: August 25, 2005. Available from www.clinical trials.gov.
21. Vlachoyiannopoulos PG. Systemic Sclerosis (Scleroderma) in:
Orphanet encyclopedia, Medical School, Department of Patophysiology,
National University of Athens; 2001. Available from
http://www.orpha.net/data/patho/GB/uk-SSc.pdf.
22. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger
TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and
pathogenesis. J Rheumatol 1988;15:202-5.
23. Denton C, Lapadula G, Mouthon L, Mller-Ladner U. Renal
complications and scleroderma renal crisis. Rheumatology 2009;48 Suppl
3:iii32-5.